After day 10, testing for IgM and IgA is recommended and may be associated with CIP tests to detect the neosynthesis of IgMs/IgGs as well as testing for IgGs, which must be monitored monthly. Here, CD79A is linked to hereditary sensory and autonomic neuropathy.